Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cell Line, Tumor"" wg kryterium: Temat


Tytuł :
Establishment of an ATLL cell line (YG-PLL) dependent on IL-2 and IL-4, which are replaced by OX40-ligand HK with poly-L-histidine and dermatan sulfate.
Autorzy :
Kagami Y; Department of Hematology, Toyota Kosei Hospital, Toyota, Aichi, Japan.; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Kato H; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Okada Y; Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Seto M; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Pokaż więcej
Źródło :
Journal of clinical and experimental hematopathology : JCEH [J Clin Exp Hematop] 2021 Sep 10; Vol. 61 (3), pp. 145-151. Date of Electronic Publication: 2021 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Line, Tumor*
Dermatan Sulfate/*pharmacology
Histidine/*pharmacology
Interleukin-2/*metabolism
Interleukin-4/*metabolism
Leukemia-Lymphoma, Adult T-Cell/*etiology
Leukemia-Lymphoma, Adult T-Cell/*metabolism
OX40 Ligand/*metabolism
Dendritic Cells, Follicular/immunology ; Dendritic Cells, Follicular/metabolism ; Gene Expression ; Humans ; Leukemia-Lymphoma, Adult T-Cell/pathology ; OX40 Ligand/genetics
Czasopismo naukowe
Tytuł :
Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
Autorzy :
Ramirez R; Gilead Sciences Inc., Foster City, California, USA.
van Buuren N; Gilead Sciences Inc., Foster City, California, USA.
Gamelin L; Gilead Sciences Inc., Foster City, California, USA.
Soulette C; Gilead Sciences Inc., Foster City, California, USA.
May L; Gilead Sciences Inc., Foster City, California, USA.
Han D; Gilead Sciences Inc., Foster City, California, USA.
Yu M; Gilead Sciences Inc., Foster City, California, USA.
Choy R; Gilead Sciences Inc., Foster City, California, USA.
Cheng G; Gilead Sciences Inc., Foster City, California, USA.
Bhardwaj N; Gilead Sciences Inc., Foster City, California, USA.
Chiu J; Gilead Sciences Inc., Foster City, California, USA.
Muench RC; Gilead Sciences Inc., Foster City, California, USA.
Delaney WE 4th; Gilead Sciences Inc., Foster City, California, USA.
Mo H; Gilead Sciences Inc., Foster City, California, USA.
Feierbach B; Gilead Sciences Inc., Foster City, California, USA.
Li L; Gilead Sciences Inc., Foster City, California, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2021 Sep 09; Vol. 95 (19), pp. e0029921. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Line, Tumor*
Transcription, Genetic*
Translocation, Genetic*
Virus Integration*
Carcinoma, Hepatocellular/*virology
DNA, Viral/*genetics
Hepatitis B virus/*genetics
Hepatitis B virus/*physiology
Humans ; Sequence Analysis, DNA ; Sequence Analysis, RNA
Czasopismo naukowe
Tytuł :
Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.
Autorzy :
Oiwa K; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Hosono N; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan. .
Nishi R; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Scotto L; The Center of Lymphoid Malignancy, Columbia University Medical Center, College of Physicians and Surgeons, 630 West 168th St, New York, NY, 10032, USA.
O'Connor OA; The Center of Lymphoid Malignancy, Columbia University Medical Center, College of Physicians and Surgeons, 630 West 168th St, New York, NY, 10032, USA.; Department of Medicine, Division of Hematology and Oncology, University of Virginia, 1215 Lee Street, Charlottesville, VA, 22903, USA.
Yamauchi T; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Jul 31; Vol. 21 (1), pp. 879. Date of Electronic Publication: 2021 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Line, Tumor*
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Aminopterin/*analogs & derivatives
Antineoplastic Agents/*pharmacology
Folic Acid Antagonists/*pharmacology
Aminopterin/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Biomarkers ; DNA Methylation ; Dose-Response Relationship, Drug ; Gene Expression Profiling ; Humans ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.
Autorzy :
Okasho K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mizuno K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Fukui T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Lin YY; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Kamiyama Y; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sunada T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Li X; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kimura H; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sumiyoshi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Goto T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Lin D; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada.
Wang Y; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada.
Collins CC; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Inoue T; Department of Nephro-Urologic Surgery, Mie University Graduate School of Medicine, Tsu, Japan.
Ogawa O; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akamatsu S; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Jul; Vol. 112 (7), pp. 2781-2791. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Carcinoma, Neuroendocrine/*pathology
Cell Line, Tumor/*pathology
Prostatic Neoplasms/*pathology
Animals ; Apoptosis Regulatory Proteins/genetics ; Carcinoma, Neuroendocrine/genetics ; Carcinoma, Neuroendocrine/secondary ; Cell Line, Tumor/metabolism ; DNA Helicases/genetics ; DNA-Binding Proteins/genetics ; Drug Screening Assays, Antitumor ; Enhancer of Zeste Homolog 2 Protein/antagonists & inhibitors ; Gene Deletion ; Gene Expression ; Genes, Neoplasm ; Genes, Retinoblastoma ; Genes, Tumor Suppressor ; Genes, p53 ; Genetic Engineering ; Heterografts ; Homozygote ; Humans ; Karyotyping ; Loss of Heterozygosity ; Male ; Mice, SCID ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Transplantation ; PTEN Phosphohydrolase/genetics ; Penile Neoplasms/genetics ; Penile Neoplasms/secondary ; Prostatic Neoplasms/genetics ; RNA-Binding Proteins/genetics ; Receptors, Androgen
Czasopismo naukowe
Tytuł :
Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models.
Autorzy :
Chung WP; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Huang WL; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Liao WA; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Huang WL; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Liu YY; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Su WC; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Pokaż więcej
Źródło :
Cancer medicine [Cancer Med] 2021 Apr; Vol. 10 (7), pp. 2370-2379. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Cell Line, Tumor*/chemistry
Cell Line, Tumor*/drug effects
Cell Line, Tumor*/metabolism
Cell Line, Tumor*/pathology
Class I Phosphatidylinositol 3-Kinases*/analysis
Class I Phosphatidylinositol 3-Kinases*/genetics
Class I Phosphatidylinositol 3-Kinases*/metabolism
Drug Resistance, Neoplasm*/genetics
PTEN Phosphohydrolase*/analysis
PTEN Phosphohydrolase*/genetics
PTEN Phosphohydrolase*/metabolism
Receptor, ErbB-2*/antagonists & inhibitors
Receptor, ErbB-2*/genetics
Receptor, ErbB-2*/metabolism
Adult ; Animals ; Antineoplastic Agents, Immunological/pharmacology ; Ascites/pathology ; Blotting, Western ; Disease Progression ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; In Situ Hybridization, Fluorescence ; MCF-7 Cells ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Mutation ; Receptors, Estrogen/analysis ; Trastuzumab/pharmacology ; Xenograft Model Antitumor Assays ; Zebrafish
Czasopismo naukowe
Tytuł :
First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.
Autorzy :
Eberhard J; Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Hirsch D; Institute of Pathology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Schilling O; Institute of Surgical Pathology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Deutsches Konsortium für Translationale Krebsforschung, Standort Freiburg, Freiburg, Germany.
Dirks WG; Department of Human and Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Guo F; Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Fabarius A; Department of Haematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Rückert F; Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. .
Reißfelder C; Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Medical Faculty Mannheim, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
Pallavi P; Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Mar 16; Vol. 11 (1), pp. 6030. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinosarcoma*/metabolism
Carcinosarcoma*/pathology
Cell Line, Tumor*
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Humans ; Male
Czasopismo naukowe
Tytuł :
Short tandem repeat profiling for the authentication of cancer stem-like cells.
Autorzy :
Visconti P; IRCCS Ospedale Policlinico San Martino, Interlab Cell Line Collection (ICLC), Biological Resource Center (CRB-HSM), Genoa, Italy.
Parodi F; IRCCS Ospedale Policlinico San Martino, Interlab Cell Line Collection (ICLC), Biological Resource Center (CRB-HSM), Genoa, Italy.
Parodi B; IRCCS Ospedale Policlinico San Martino, Interlab Cell Line Collection (ICLC), Biological Resource Center (CRB-HSM), Genoa, Italy.
Casarino L; Department of Legal and Forensic Medicine, University of Genoa, Genoa, Italy.
Romano P; IRCCS Ospedale Policlinico San Martino, Proteomics Service, Scientific Direction, Genoa, Italy.
Buccarelli M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Pallini R; Fondazione Policlinico Universitario A. Gemelli IRCCS - Institute of Neurosurgery, Catholic University School of Medicine, Rome, Italy.
D'Alessandris QG; Fondazione Policlinico Universitario A. Gemelli IRCCS - Institute of Neurosurgery, Catholic University School of Medicine, Rome, Italy.
Montori A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University 'La Sapienza', Rome, Italy.
Pilozzi E; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University 'La Sapienza', Rome, Italy.
Ricci-Vitiani L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Mar 15; Vol. 148 (6), pp. 1489-1498. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Line, Tumor*
Microsatellite Repeats*
Neoplastic Stem Cells*
Cell Line Authentication/*methods
Cell Line Authentication/*standards
Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/genetics ; Datasets as Topic ; Female ; Gene Expression Profiling/methods ; Gene Expression Profiling/standards ; Glioblastoma/genetics ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.
Autorzy :
Lanigan LG; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio; Tox Path Specialists, a StageBio Company, Fredrick, Maryland.
Hildreth BE 3rd; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
Dirksen WP; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Simmons JK; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Martin CK; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio; Department of Pathology and Microbiology, University of Prince Edward Island, Atlantic Veterinary College, Prince Edward Island, Canada.
Werbeck JL; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Thudi NK; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Papenfuss TL; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Boyaka PN; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Toribio RE; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Ward JM; Global VetPathology, Montgomery Village, Maryland.
Weilbaecher KN; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Rosol TJ; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio; Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio. Electronic address: .
Pokaż więcej
Źródło :
The American journal of pathology [Am J Pathol] 2021 Feb; Vol. 191 (2), pp. 335-352. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Cell Line, Tumor*
Disease Models, Animal*
Genes, pX*
Histiocytic Sarcoma*/pathology
Histiocytic Sarcoma*/virology
HTLV-I Infections/*complications
Animals ; Carcinogenesis/genetics ; Human T-lymphotropic virus 1/genetics ; Humans ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Oncogenes ; Osteolysis/pathology ; Osteolysis/virology
Czasopismo naukowe
Tytuł :
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
Autorzy :
Karnezis AN; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of California, Davis Medical Center, Sacramento, CA, USA.
Chen SY; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Chow C; Genetic Pathology Evaluation Centre, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
Yang W; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Hendricks WPD; Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Ramos P; Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Briones N; Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Mes-Masson AM; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada; Department of Medicine, Université de Montréal, Montreal, QC, Canada.
Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Trent JM; Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Weissman B; Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Huntsman DG; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada. Electronic address: .
Wang Y; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2021 Feb; Vol. 160 (2), pp. 568-578. Date of Electronic Publication: 2020 Dec 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Ovarian Epithelial/*diagnosis
Carcinoma, Small Cell/*diagnosis
Cell Line, Tumor/*pathology
Ovarian Neoplasms/*diagnosis
Animals ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/pathology ; Carcinoma, Small Cell/drug therapy ; Carcinoma, Small Cell/genetics ; Carcinoma, Small Cell/pathology ; Cell Dedifferentiation/genetics ; Cell Line, Tumor/drug effects ; DNA Helicases/analysis ; DNA Helicases/deficiency ; DNA Helicases/genetics ; Enhancer of Zeste Homolog 2 Protein/antagonists & inhibitors ; Female ; Gene Expression Profiling ; Humans ; Mice ; Nuclear Proteins/analysis ; Nuclear Proteins/deficiency ; Nuclear Proteins/genetics ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Transcription Factors/analysis ; Transcription Factors/deficiency ; Transcription Factors/genetics ; Whole Exome Sequencing ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells.
Autorzy :
Alizadeh Zarei M; Department of Medical Biotechnology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran; Diagnostic Laboratory Sciences and Technology Research Center, Paramedical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Rafiei Dehbidi G; Diagnostic Laboratory Sciences and Technology Research Center, Paramedical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Takhshid MA; Department of Medical Biotechnology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran; Diagnostic Laboratory Sciences and Technology Research Center, Paramedical School, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: .
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2020 Nov; Vol. 38 (11), pp. 849.e1-849.e9. Date of Electronic Publication: 2020 Jul 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Apoptosis/*radiation effects
Cell Line, Tumor/*drug effects
Cell Line, Tumor/*radiation effects
Cell Survival/*drug effects
Cell Survival/*radiation effects
Docetaxel/*pharmacology
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*pathology
Tumor Suppressor Proteins/*genetics
Apoptosis/genetics ; Cell Line, Tumor/pathology ; Cell Survival/genetics ; Humans ; Male ; Neoplasm Invasiveness/genetics ; X-Rays
Czasopismo naukowe
Tytuł :
[In silico exploration of databases is no longer a fighting sport].
Autorzy :
Robert J; Université de Bordeaux, INSERM U1218, 33000 Bordeaux, France. Electronic address: .
Pokaż więcej
Transliterated Title :
L’exploration des bases de données in silico n’est plus un sport de combat.
Źródło :
Bulletin du cancer [Bull Cancer] 2021 Jan; Vol. 108 (1), pp. 14-17. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Editorial
MeSH Terms :
Cell Line, Tumor*
Databases, Genetic/*trends
Neoplasms/*genetics
Genetic Markers ; Humans ; Metaphor ; National Cancer Institute (U.S.) ; Pharmacogenetics ; Sports ; United States
Opinia redakcyjna
Tytuł :
U-RT1 - A new model for Richter transformation.
Autorzy :
Schmid T; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Maier J; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Martin M; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Tasdogan A; Institute of Immunology, University Hospital Ulm, Ulm, Germany.
Tausch E; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Barth TFE; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Stilgenbauer S; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Bloehdorn J; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Möller P; Institute of Pathology, University Hospital Ulm, Ulm, Germany. Electronic address: .
Mellert K; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Pokaż więcej
Źródło :
Neoplasia (New York, N.Y.) [Neoplasia] 2021 Jan; Vol. 23 (1), pp. 140-148. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Line, Tumor*
Leukemia, Lymphocytic, Chronic, B-Cell/*pathology
Apoptosis/genetics ; Biomarkers ; Biomarkers, Tumor ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Comparative Genomic Hybridization ; Disease Progression ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Karyotype ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Male ; Middle Aged ; Mutation ; Primary Cell Culture
Czasopismo naukowe
Tytuł :
In vitro cytotoxic and genotoxic effect of the crude and ethanolic extract from the rhizome of Curcuma longa L.
Autorzy :
Cosquillo-Rafael MF; Grupo de Investigación «Farmacognosia y Medicina Tradicional», Universidad Nacional Mayor de San Marcos, Lima, Perú.
Placencia-Medina MD; Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Perú.
Miranda-Tomasevich TY; Centro de Investigación en Biología Molecular y Bioinformática, Universidad Nacional de San Cristóbal de Huamanga, Ayacucho, Perú.
Moreno-Hinojosa M; Centro de Investigación en Biología Molecular y Bioinformática, Universidad Nacional de San Cristóbal de Huamanga, Ayacucho, Perú.
Retuerto-Figueroa MG; Grupo de Investigación «Farmacognosia y Medicina Tradicional», Universidad Nacional Mayor de San Marcos, Lima, Perú.
Pokaż więcej
Transliterated Title :
Efecto citotóxico y genotóxico in vitro del extracto crudo y etanólico del rizoma de Curcuma longa L.
Źródło :
Revista peruana de medicina experimental y salud publica [Rev Peru Med Exp Salud Publica] 2020 Dec 02; Vol. 37 (3), pp. 454-461.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Line, Tumor*/drug effects
Curcuma*
Plant Extracts*/pharmacology
Rhizome*
Curcumin/pharmacology ; Cytotoxins ; DNA Damage/drug effects ; Ethanol ; Humans ; Inhibitory Concentration 50
Czasopismo naukowe
Tytuł :
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity.
Autorzy :
Bastiaenen VP; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Klaver CEL; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
van der Heijden MCS; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Nijman LE; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Lecca MC; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Tanis PJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Lenos KJ; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands.
Vermeulen L; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands. .; Oncode Institute, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło :
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2020 Nov; Vol. 100 (11), pp. 1465-1474. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Line, Tumor*
Colorectal Neoplasms/*pathology
Peritoneal Neoplasms/*secondary
Peritoneum/*pathology
Animals ; Female ; HCT116 Cells ; Humans ; Mice, Nude ; Neoplasms, Experimental
Czasopismo naukowe
Tytuł :
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity.
Autorzy :
Kinker GS; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Institute of Bioscience, University of Sao Paulo, Sao Paulo, Brazil.
Greenwald AC; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Tal R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Orlova Z; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Cuoco MS; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
McFarland JM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Warren A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Rodman C; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Roth JA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Bender SA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Kumar B; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Rocco JW; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Fernandes PACM; Institute of Bioscience, University of Sao Paulo, Sao Paulo, Brazil.
Mader CC; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Keren-Shaul H; The Nancy & Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.; Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.
Plotnikov A; The Nancy & Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
Barr H; The Nancy & Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
Tsherniak A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Rozenblatt-Rosen O; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Krizhanovsky V; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Puram SV; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA.
Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. .
Pokaż więcej
Źródło :
Nature genetics [Nat Genet] 2020 Nov; Vol. 52 (11), pp. 1208-1218. Date of Electronic Publication: 2020 Oct 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Line, Tumor*/drug effects
Genetic Heterogeneity*
Neoplasms/*genetics
Precancerous Conditions/*genetics
Cellular Senescence/genetics ; Drug Screening Assays, Antitumor ; Humans ; RNA-Seq ; Stress, Physiological/genetics ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.
Autorzy :
Serej ZA; Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Ebrahimi A; Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Halic University, Istanbul, Turkey.
Kazemi T; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Najafi S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amini M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nastarin P; Department of Orthodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
Baghbani E; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2021 Oct 30; Vol. 801, pp. 145844. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
MicroRNAs/*genetics
Nanog Homeobox Protein/*genetics
Antigens, CD/genetics ; Apoptosis/genetics ; Cadherins/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Female ; Gene Expression Regulation, Neoplastic ; HMGA2 Protein/genetics ; Humans ; Nanog Homeobox Protein/metabolism ; Neoplastic Stem Cells/pathology ; Octamer Transcription Factor-3/genetics ; RNA, Small Interfering ; RNA-Binding Proteins/genetics ; Spheroids, Cellular/pathology ; Transfection ; Vimentin/genetics
Czasopismo naukowe
Tytuł :
Biomineralized separation, concentration, and evaluation of the effectiveness of Schisandra chinensis fruit extract.
Autorzy :
Hwang ET; Department of Food Biotechnology, Dong-A University, Busan 49315, Republic of Korea. Electronic address: .
Joo YE; GeneCellPharm Corporation, Seoul 05836, Republic of Korea.
Kim KR; GeneCellPharm Corporation, Seoul 05836, Republic of Korea.
Jeong J; Symbiose Cosmetics, Seongnam-si, Gyeonggi-do 13555, Republic of Korea.
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2021 Oct 30; Vol. 360, pp. 130063. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
Plant Extracts/*chemistry
Schisandra/*chemistry
Animals ; Antioxidants/chemistry ; Cell Line, Tumor ; Cell Survival/drug effects ; Cyclooctanes/chemistry ; Cyclooctanes/isolation & purification ; Cyclooctanes/pharmacology ; Fruit/chemistry ; Fruit/metabolism ; Lignans/chemistry ; Lignans/isolation & purification ; Lignans/pharmacology ; Mice ; Plant Extracts/pharmacology ; Polycyclic Compounds/chemistry ; Polycyclic Compounds/isolation & purification ; Polycyclic Compounds/pharmacology ; Schisandra/metabolism
Czasopismo naukowe
Tytuł :
Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles - Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment.
Autorzy :
Parvathaneni V; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Shukla SK; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Kulkarni NS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Gupta V; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2021 Oct 25; Vol. 608, pp. 121038. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji :
Journal Article
MeSH Terms :
Amodiaquine*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Nanoparticles*
A549 Cells ; Cell Line, Tumor ; Drug Delivery Systems ; Humans ; Transferrin
Czasopismo naukowe
Tytuł :
Benzofuranyl-2-imidazoles as imidazoline I 2 receptor ligands for Alzheimer's disease.
Autorzy :
Rodriguez-Arévalo S; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Bagán A; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Griñán-Ferré C; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Vasilopoulou F; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Pallàs M; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Brocos-Mosquera I; Department of Pharmacology, University of the Basque Country, UPV/EHU, E-48940, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain.
Callado LF; Department of Pharmacology, University of the Basque Country, UPV/EHU, E-48940, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain.
Loza MI; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain.
Martínez AL; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain.
Brea J; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain.
Pérez B; Department of Pharmacology, Therapeutic and Toxicology, Autonomous University of Barcelona, E-08193, Cerdanyola, Spain.
Molins E; Institut de Ciència de Materials de Barcelona (CSIC), Campus UAB, E-08193, Cerdanyola, Spain.
De Jonghe S; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000, Leuven, Belgium.
Daelemans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000, Leuven, Belgium.
Radan M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia.
Djikic T; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia.
Nikolic K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia.
Hernández-Hernández E; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain.
García-Fuster MJ; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain.
García-Sevilla JA; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain.
Escolano C; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain. Electronic address: .
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2021 Oct 15; Vol. 222, pp. 113540. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease/*drug therapy
Benzofurans/*pharmacology
Imidazoles/*pharmacology
Imidazoline Receptors/*antagonists & inhibitors
Alzheimer Disease/metabolism ; Animals ; Apoptosis/drug effects ; Benzofurans/chemical synthesis ; Benzofurans/chemistry ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Humans ; Imidazoles/chemical synthesis ; Imidazoles/chemistry ; Imidazoline Receptors/metabolism ; Ligands ; Male ; Mice ; Molecular Structure ; Oxidative Stress/drug effects ; Structure-Activity Relationship
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies